5 completed, 3 unknown, 1 recruiting, 1 withdrawn. 1 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Healthy Control: new trials by email Literature Review of Healthy Control trials Research Report on Healthy Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Understanding the Natural History Early in the Course or Presentation of Friedreich Ataxia Geneticlly confirmed disease causing FXN mutatuion, Healthy Control - Friedreich Ataxia, Rare Diseases | Withdrawn | Friedreich's Ataxia Research Alliance | 2025-05-01 | 2025-06-08 | ||
| Lung and Heart Function Across Decades of Life in Health Healthy control - Pollution Related Respiratory Disorder, Pollution; Exposure | Recruiting | University of California, San Francisco | 200 | 2024-08-01 | 2026-09-14 | |
| PET-CT-based Study of Central Mechanisms of Cortical Metabolism in 18F-FDG and 18F-AV1451 Age-related Deafness hearing aids, without hearing intervention, healthy control - Age-related Hearing Loss, PET-CT | Unknown | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 30 | 2022-07-06 | 2023-04-03 | |
| Decoding Pain Sensitivity in Migraine With Multimodal Brainstem-based Neurosignature Flunarizine, healthy control - Migraine | Phase 4 | Unknown | Taipei Veterans General Hospital, Taiwan | 600 | 2021-02-26 | 2021-04-14 |
| Factors That Impact the Relationship Between Pulmonary Status and Susceptibility to Electronic Cigarette Use Pulmonary Group, Healthy Control - Electronic Cigarette Use, Pulmonary Disease | Completed | University of Alabama at Birmingham | 200 | 2020-01-01 | 2021-05-25 | |
| A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression Escitalopram, Duloxetine, Bupropion - Major Depressive Disorder, Depression, Unipolar | Early Phase 1 | Unknown | Yuqi Cheng | 200 | 2018-08-01 | 2019-09-17 |
| Predictor of Clinical Response to Acthar in Myositis Healthy Control, Myositis in Remission - Myositis, Dermatomyositis | Completed | University of Pittsburgh | 20 | 2017-11-06 | 2022-08-09 | |
| Pain Phenotypes in Knee Osteoarthritis Knee Osteoarthritis, Healthy Control - Osteoarthritis, Knee, Pain | Completed | University of Colorado, Denver | 187 | 2013-04-01 | 2016-06-16 | |
| Hypoxia Inducible Factor 1 Alpha as a Novel Biomarker in Septic Shock Septic patients, Healthy Control - Sepsis | Completed | University of Florida | 63 | 2013-01-01 | 2016-10-13 | |
| Exploring Biomarkers for Depression Escitalopram, Healthy Control - Major Depressive Disorder | Completed | Wyss Institute at Harvard University | 51 | 2011-08-01 | 2018-05-01 |
Depressive Disorder, Major (2) · Depression (1) · Depressive Disorder (1) · Dermatomyositis (1) · Dyspnea (1) · Friedreich Ataxia (1) · Lung Diseases (1) · Migraine Disorders (1) · Myositis (1) · Osteoarthritis, Knee (1) · Pain (1) · Polymyositis (1) · Presbycusis (1) · Rare Diseases (1) · Sepsis (1)
Friedreich's Ataxia Research Alliance (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1) · Taipei Veterans General Hospital, Taiwan (1) · University of Alabama at Birmingham (1) · University of California, San Francisco (1) · University of Colorado, Denver (1) · University of Florida (1) · University of Pittsburgh (1) · Wyss Institute at Harvard University (1) · Yuqi Cheng (1)
United States (7) · China (2) · Australia (1) · Canada (1) · Germany (1) · Italy (1) · Taiwan (1)
Andrew Nierenberg, MD (1) · Diana Young, Ph.D (1) · Jennifer E Stevens-Lapsley, PT, PhD (1) · Jennifer Farmer (1) · Mehrdad Arjomandi, MD (1) · Rohit Aggarwal, MD (1) · Tommi Raij, MD, Ph.D (1) · Wael Nasser, MD (1)